Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris

References

• Jennings R. B., Murry C. E., Steenbergen C., Jr., Reimer K. A. Development of cell injury in sustained acute ischemia. Circulation 1990; 82: II2–12
   PubMedGoogle Scholar
• Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111: 3481–8
   PubMed Web of Science ®Google Scholar
• Brener S. J. Insights into the pathophysiology of ST‐elevation myocardial infarction. Am Heart J 2006; 151: S4–10
   PubMedGoogle Scholar
• Antman E. M., Anbe D. T., Armstrong P. W., Bates E. R., Green L. A., Hand M., et al. ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82–292
   PubMed Web of Science ®Google Scholar
• Frangogiannis N. G., Smith C. W., Entman M. L. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31–47
   PubMed Web of Science ®Google Scholar
• Lefer D. J., Granger D. N. Oxidative stress and cardiac disease. Am J Med 2000; 109: 315–23
   PubMed Web of Science ®Google Scholar
• Lenardo M. J., Baltimore D. NF‐kappa B: a pleiotropic mediator of inducible and tissue‐specific gene control. Cell 1989; 58: 227–9
   PubMed Web of Science ®Google Scholar
• Oyama J., Blais C., Jr., Liu X., Pu M., Kobzik L., Kelly R. A., et al. Reduced myocardial ischemia‐reperfusion injury in toll‐like receptor 4‐deficient mice. Circulation 2004; 109: 784–9
   PubMed Web of Science ®Google Scholar
• Rossen R. D., Michael L. H., Kagiyama A., Savage H. E., Hanson G., Reisberg M. A., et al. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circ Res 1988; 62: 572–84
   PubMed Web of Science ®Google Scholar
• Krown K. A., Page M. T., Nguyen C., Zechner D., Gutierrez V., Comstock K. L., et al. Tumor necrosis factor alpha‐induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996; 98: 2854–65
   PubMed Web of Science ®Google Scholar
• Kubota T., McTiernan C. F., Frye C. S., Slawson S. E., Lemster B. H., Koretsky A. P., et al. Dilated cardiomyopathy in transgenic mice with cardiac‐specific overexpression of tumor necrosis factor‐alpha. Circ Res 1997; 81: 627–35
   PubMed Web of Science ®Google Scholar
• Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio‐Pulkki L. M., et al. Cardiomyocyte apoptosis and ventricular remodelling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2001; 280: H2726–31
   PubMed Web of Science ®Google Scholar
• Yokoyama T., Nakano M., Bednarczyk J. L., McIntyre B. W., Entman M., Mann D. L. Tumor necrosis factor‐alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997; 95: 1247–52
   PubMed Web of Science ®Google Scholar
• Nian M., Lee P., Khaper N., Liu P. Inflammatory cytokines and postmyocardial infarction remodelling. Circ Res 2004; 94: 1543–53
   PubMed Web of Science ®Google Scholar
• Frangogiannis N. G. The mechanistic basis of infarct healing. Antioxid Redox Signal 2006; 8: 1907–39
   PubMed Web of Science ®Google Scholar
• Ren G., Dewald O., Frangogiannis N. G. Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy 2003; 2: 242–56
   PubMedGoogle Scholar
• Hoffmann P., Halvorsen S., Stensaeth K. H., Brekke M., Muller C., Anker G. O., et al. Myocardial perfusion in ST‐elevation myocardial infarction treated successfully with primary angioplasty. Scand Cardiovasc J 2006; 40: 96–104
   PubMed Web of Science ®Google Scholar
• Frangogiannis N. G., Lindsey M. L., Michael L. H., Youker K. A., Bressler R. B., Mendoza L. H., et al. Resident cardiac mast cells degranulate and release preformed TNF‐alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 1998; 98: 699–710
   PubMed Web of Science ®Google Scholar
• Belosjorow S., Schulz R., Dorge H., Schade F. U., Heusch G. Endotoxin and ischemic preconditioning: TNF‐alpha concentration and myocardial infarct development in rabbits. Am J Physiol 1999; 277: H2470–5
   PubMedGoogle Scholar
• Dewald O., Ren G., Duerr G. D., Zoerlein M., Klemm C., Gersch C., et al. Of mice and dogs: species‐specific differences in the inflammatory response following myocardial infarction. Am J Pathol 2004; 164: 665–77
   PubMed Web of Science ®Google Scholar
• Frangogiannis N. G., Youker K. A., Rossen R. D., Gwechenberger M., Lindsey M. H., Mendoza L. H., et al. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol 1998; 30: 2567–76
   PubMed Web of Science ®Google Scholar
• Sack M. N., Smith R. M., Opie L. H. Tumor necrosis factor in myocardial hypertrophy and ischaemia – an anti‐apoptotic perspective. Cardiovasc Res 2000; 45: 688–95
   PubMed Web of Science ®Google Scholar
• Gwechenberger M., Mendoza L. H., Youker K. A., Frangogiannis N. G., Smith C. W., Michael L. H., et al. Cardiac myocytes produce interleukin‐6 in culture and in viable border zone of reperfused infarctions. Circulation 1999; 99: 546–51
   PubMed Web of Science ®Google Scholar
• Kukielka G. L., Smith C. W., Manning A. M., Youker K. A., Michael L. H., Entman M. L. Induction of interleukin‐6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 1995; 92: 1866–75
   PubMed Web of Science ®Google Scholar
• Finkel M. S., Oddis C. V., Jacob T. D., Watkins S. C., Hattler B. G., Simmons R. L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–9
   PubMed Web of Science ®Google Scholar
• Finkel M. S., Hoffman R. A., Shen L., Oddis C. V., Simmons R. L., Hattler B. G. Interleukin‐6 (IL‐6) as a mediator of stunned myocardium. Am J Cardiol 1993; 71: 1231–2
   PubMed Web of Science ®Google Scholar
• Gallucci R. M., Simeonova P. P., Matheson J. M., Kommineni C., Guriel J. L., Sugawara T., et al. Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice. FASEB J 2000; 14: 2525–31
   PubMed Web of Science ®Google Scholar
• Aggarwal A., Schneider D. J., Terrien E. F., Gilbert K. E., Dauerman H. L. Increase in interleukin‐6 in the first hour after coronary stenting: an early marker of the inflammatory response. J Thromb Thrombolysis 2003; 15: 25–31
   PubMedGoogle Scholar
• Liuzzo G., Buffon A., Biasucci L. M., Gallimore J. R., Caligiuri G., Vitelli A., et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98: 2370–6
   PubMed Web of Science ®Google Scholar
• de Beer F. C., Hind C. R., Fox K. M., Allan R. M., Maseri A., Pepys M. B. Measurement of serum C‐reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982; 47: 239–43
   PubMedGoogle Scholar
• James S. K., Oldgren J., Lindback J., Johnston N., Siegbahn A., Wallentin L. An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease. Am Heart J 2005; 149: 619–26
   PubMed Web of Science ®Google Scholar
• Griselli M., Herbert J., Hutchinson W. L., Taylor K. M., Sohail M., Krausz T., et al. C‐reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999; 190: 1733–40
   PubMed Web of Science ®Google Scholar
• Lagrand W. K., Niessen H. W., Wolbink G. J., Jaspars L. H., Visser C. A., Verheugt F. W., et al. C‐reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997; 95: 97–103
   PubMed Web of Science ®Google Scholar
• Anzai T., Yoshikawa T., Shiraki H., Asakura Y., Akaishi M., Mitamura H., et al. C‐reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q‐wave acute myocardial infarction. Circulation 1997; 96: 778–84
   PubMed Web of Science ®Google Scholar
• Pietila K. O., Harmoinen A. P., Jokiniitty J., Pasternack A. I. Serum C‐reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow‐up in patients under thrombolytic treatment. Eur Heart J 1996; 17: 1345–9
   PubMed Web of Science ®Google Scholar
• Ueda S., Ikeda U., Yamamoto K., Takahashi M., Nishinaga M., Nago N., Shimada K. C‐reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am Heart J 1996; 131: 857–60
   PubMedGoogle Scholar
• Bello D., Fieno D. S., Kim R. J., Pereles F. S., Passman R., Song G., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005; 45: 1104–8
   PubMed Web of Science ®Google Scholar
• Kakio T., Matsumori A., Ono K., Ito H., Matsushima K., Sasayama S. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein‐1 in the ischemic and reperfused rat heart. Lab Invest 2000; 80: 1127–36
   PubMedGoogle Scholar
• Kumar A. G., Ballantyne C. M., Michael L. H., Kukielka G. L., Youker K. A., Lindsey M. L., et al. Induction of monocyte chemoattractant protein‐1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 1997; 95: 693–700
   PubMed Web of Science ®Google Scholar
• Frangogiannis N. G., Mendoza L. H., Lindsey M. L., Ballantyne C. M., Michael L. H., Smith C. W., et al. IL‐10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol 2000; 165: 2798–808
   PubMed Web of Science ®Google Scholar
• Yang Z., Zingarelli B., Szabo C. Crucial role of endogenous interleukin‐10 production in myocardial ischemia/reperfusion injury. Circulation 2000; 101: 1019–26
   PubMed Web of Science ®Google Scholar